InMed Pharma - INM Net earnings per share for the last four quarters

Public company logo of InMed Pharmaceuticals Inc (INM)

The volatility of InMed Pharmaceuticals (INM), which develops medical cannabinoids for cosmetology and pharmacy, is evident through the annual variability of TTM net income per share. Risks are mitigated by the synthesis of components for dermatology and ophthalmology, although the business relies solely on existing capital without active sales. The value of 54.60 expresses the metric's value today, capturing the company's current level of financial stability.

INM: InMed Pharmaceuticals Inc. Earnings per share for the last twelve months 02/11/2024 - 11/09/2026

InMed Pharmaceuticals Inc. - analytical breakdowns and key metrics (INM)

Fundamental valuation:InMed Pharmaceuticals Inc INM
Core merchandise of inmedpharma.com

InMed Pharmaceuticals (INM) maintains a strong position in the niche rare cannabinoid biosynthesis segment due to its patent protection. By analyzing the EPS YoY TTM growth, investors assess the dynamics of the rolling earnings per share. This indicator neutralizes discrepancies between GAAP and Non-GAAP standards, revealing the actual cash flow. For a company with early-stage medical programs, this pace reflects the scaling efficiency of the Integria technology. The market is currently pricing in the balance between current growth and the risk of capital volatility.

Competitor analysis

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Earnings per share for the last twelve months|India Globalization Capital - Earnings per share for the trailing year|Earnings per share for the last twelve months MIRA Pharma|FLGC: Earnings per share for the trailing year|Earnings per share for the last twelve months IMC (IMCC)|ADIL: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) ARTL (Artelo)|Earnings per share for the trailing year ENSC|Titan Pharmaceuticals - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Greenlane Holdings|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO